Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 190.75-6.18-66.140.2217.80

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is 190.75 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025190.75
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 190.75
Positive
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,887.1 Cr -0.7% 8.4% 65% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹107,043.0 Cr -1.9% -0.3% -6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.7%

8.4%

65%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses